lenacapavir yeztugo - Search News

News

FDA approval of new HIV prevention drug is a big deal

Revolutionary Drug That's “Closest Thing” To HIV Vaccine Gets FDA Approval

The Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that has been shown to act as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV. The drug,

MPR · 4h

Twice-Yearly HIV-1 PrEP Yeztugo Gets FDA Approval

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Greek Reporter · 1h

FDA Approves New HIV Prevention Shot Given Twice a Year

The US Food and Drug Administration (FDA) has approved a new shot to prevent HIV, offering a long-acting alternative to daily pills.

Managed Healthcare Executive20h

With Lenacapavir 'You've Basically Got a Vaccine.' But Reaching the People Who Would Benefit Is Difficult, Says Gates Foundation Expert

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

BMO says lenacapavir approval for prevention a ‘major win’ for Gilead

Although largely as expected by investors, BMO Capital says lenacapavir’s approval for prevention, now known as Yeztugo, marks “a major win for Gilead (GILD)” in driving meaningful growth in its ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

FDA approval of new HIV prevention drug is a big deal

Trending now